ArticleInternational cancer conference journal2024

High likelihood of BRCA2 reversion mutation in pancreatic cancer post-platinum-based chemotherapy: a case study.

Taro Hanaoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.